CNB Bank Has $2.14 Million Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

CNB Bank lowered its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 4,096 shares of the medical equipment provider’s stock after selling 91 shares during the period. Intuitive Surgical makes up approximately 1.0% of CNB Bank’s portfolio, making the stock its 23rd biggest holding. CNB Bank’s holdings in Intuitive Surgical were worth $2,138,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its position in shares of Intuitive Surgical by 10.2% during the second quarter. Dimensional Fund Advisors LP now owns 572,934 shares of the medical equipment provider’s stock valued at $254,872,000 after purchasing an additional 52,976 shares in the last quarter. Moors & Cabot Inc. boosted its stake in Intuitive Surgical by 2.3% in the second quarter. Moors & Cabot Inc. now owns 1,159 shares of the medical equipment provider’s stock valued at $516,000 after acquiring an additional 26 shares during the last quarter. Wealth Alliance grew its position in shares of Intuitive Surgical by 2.7% during the 2nd quarter. Wealth Alliance now owns 2,796 shares of the medical equipment provider’s stock valued at $1,244,000 after acquiring an additional 74 shares during the period. Mercer Global Advisors Inc. ADV increased its stake in shares of Intuitive Surgical by 11.5% during the 2nd quarter. Mercer Global Advisors Inc. ADV now owns 45,393 shares of the medical equipment provider’s stock worth $20,172,000 after purchasing an additional 4,694 shares during the last quarter. Finally, Sienna Gestion raised its holdings in shares of Intuitive Surgical by 5.3% in the 2nd quarter. Sienna Gestion now owns 17,036 shares of the medical equipment provider’s stock worth $7,575,000 after purchasing an additional 853 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This represents a 1.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 48,190 shares of company stock valued at $25,012,927 over the last three months. Corporate insiders own 0.80% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have issued reports on the company. Citigroup boosted their target price on Intuitive Surgical from $567.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, December 11th. Stifel Nicolaus boosted their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a report on Friday, October 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Price Performance

ISRG stock opened at $584.23 on Friday. The stock has a market capitalization of $208.09 billion, a P/E ratio of 94.19, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $362.14 and a 1-year high of $590.07. The business has a fifty day moving average price of $538.34 and a 200-day moving average price of $497.08.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.